🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07789301
Recruiting Observational

Predictors of Severe Postoperative Pain Within 24 Hours After Elective Cesarean Delivery Under Spinal Anesthesia

NCT07789301 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-07-15
Last updated
2026-08-27

Condition(s) studied

Cesarean SectionPostoperative Pain After Cesarean SectionAcute Pain

Investigational drug(s) / intervention(s)

Observational Assessment of Postoperative Pain

Observational Assessment of Postoperative Pain: Participants will receive routine spinal anesthesia and standard perioperative care for elective cesarean delivery. Preoperative, intraoperative, and postoperative variables will be recorded without any study-specific intervention.

Study summary

This prospective observational study aims to identify predictors of severe postoperative pain during the first 24 hours after elective cesarean delivery under spinal anesthesia. Preoperative, intraoperative, and postoperative factors will be evaluated to determine their association with severe postoperative pain.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Pregnant women aged 18-45 years. * Elective cesarean delivery under spinal anesthesia. * Ability to understand Turkish. * Written informed consent. Exclusion Criteria: * Emergency cesarean delivery. * Conversion to general anesthesia. * Major obstetric hemorrhage. * Intensive care requirement. * Chronic opioid use. * Severe psychiatric or neurological disease. * Inability to communicate.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bursa City Hospital Bursa Nilüfer Recruiting

More Bursa City Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07789301 on ClinicalTrials.gov ↗ ← All trials in Turkey